
Pneumonia is a serious lung infection that can be life-threatening for seniors, especially those with other health conditions or a weakened immune system. The pneumococcal vaccine is an injected medicine that can protect against and often prevent pneumococcal disease, which causes pneumonia. In the United States, there are two types of pneumococcal vaccines recommended for seniors aged 65 or older: PCV15 and PCV20. These vaccines protect against 15 and 20 types of bacteria that cause pneumococcal disease, respectively. While the older vaccines, PCV13 and PPSV23, do not protect against all types of pneumonia, the newer vaccines can make it less likely for seniors to experience severe and possibly life-threatening complications from the illness.
| Characteristics | Values |
|---|---|
| Number of different types of pneumonia vaccines for seniors | 2 |
| Recommended age for seniors | 65 or older |
| Names of the vaccines | Pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) |
| Other names for the vaccines | PCV15, PCV20, PCV21 |
| What the vaccines protect against | Pneumococcal disease, a serious bacterial infection |
| How many shots are needed | 2 |
| How often are the shots administered | One year apart |
| Who else can take the vaccines | Adults 19 to 64 with certain medical conditions or risk factors |
| Side effects | Mild and usually go away within 2 days |
| Cost | Free or covered by insurance |
Explore related products
What You'll Learn

PCV15 and PCV20 are recommended for seniors
Pneumococcal disease is a severe bacterial infection that can affect the lungs, blood, and brain. It is caused by pneumococcal bacteria, which commonly live in the nose and throat. Older adults are at high risk for complications from this disease and the flu, so it is important to get vaccinated. Pneumococcal vaccines can prevent you from getting illnesses caused by pneumococcal bacteria, including pneumonia, ear infections, sinus infections, and meningitis.
There are two main types of pneumococcal vaccines used in the United States: pneumococcal conjugate vaccines (PCVs) and pneumococcal polysaccharide vaccines (PPSV). PCV15 and PCV20 are recommended for seniors aged 65 and older, as well as adults 19 through 64 with certain medical conditions or risk factors. PCV15 protects against 15 types of bacteria that cause pneumococcal disease, while PCV20 protects against 20 types. These vaccines are safe and effective, and most people do not experience any serious side effects.
The CDC recommends routine pneumococcal vaccination for all children younger than five years old, with a 4-dose PCV series (PCV15 or PCV20) administered at different ages. For children who miss their shots or start the series later, it is still recommended to get either PCV15 or PCV20. The CDC also recommends pneumococcal vaccination for adults over 50, especially those at high risk, such as those with weakened immune systems or certain medical conditions.
It is important to note that pneumococcal vaccines cannot prevent all cases of pneumonia, but they can significantly lower the chances of catching the infection and reduce the severity of the illness. Seniors who have not received either vaccine should get a single dose of PCV20 or PCV15, as advised by their healthcare provider. These vaccines are available for free or covered by insurance plans for those who qualify.
California Vaccine Lottery: How to Enter and Win
You may want to see also
Explore related products
$12.99

PCV15 protects against 15 types of bacteria
Pneumonia, also known as pneumococcal disease, is caused by Streptococcus pneumoniae bacteria, or pneumococcus. Pneumococcal bacteria can cause pneumonia, ear infections, sinus infections, meningitis, and blood infections. Pneumonia is a serious disease that infects the air sacs of the lungs, causing them to fill with fluid or pus. As a result, patients may develop a cough, fever, chills, and trouble breathing. Pneumonia can quickly become life-threatening for older adults, especially those with other health conditions or a weakened immune system.
The pneumonia vaccine can help prevent pneumococcal disease. There are two main types of pneumococcal vaccines: Pneumococcal Conjugate Vaccines (PCVs) and Pneumococcal Polysaccharide Vaccine (PPSV23). PCV15, a type of PCV, protects against 15 types of bacteria that cause pneumococcal disease. PCV15 is recommended for children under the age of 5 and adults over the age of 65. Children under the age of 2 are recommended to receive the vaccine in a four-dose series at 2, 4, 6, and 12-15 months. If a child misses these shots, they should still get PCV15 or PCV20 and follow the recommended dosing and schedule. Similarly, adults over the age of 65 should consult their doctor about getting PCV15 or PCV20.
PCV15 is a safe and effective vaccine, with only mild side effects such as redness, swelling, or pain at the injection site. It is also likely to be available for free, especially for those with Medicare Part B, Medicaid, or private health insurance plans. PCV15 can help prevent pneumococcal disease and reduce the risk of infection, protecting against 15 types of bacteria.
Immunizations: Facts and Truths You Need to Know
You may want to see also
Explore related products

PCV20 protects against 20 types of bacteria
Pneumonia is a serious disease that affects the air sacs in the lungs, causing them to fill with fluid or pus. It can result in a cough, fever, chills, and trouble breathing. Pneumonia can quickly become life-threatening for older adults, especially those with other health conditions or a weakened immune system.
Pneumococcal bacteria are a common cause of pneumonia. The pneumococcal vaccine, also known as the pneumonia vaccine, is given to prevent infection caused by Streptococcus pneumoniae bacteria, or pneumococcus. Pneumococcal conjugate vaccines (PCVs) are differentiated by the number of serotypes they protect against. PCV20, also known as Prevnar20®, is a pneumococcal conjugate vaccine that protects against 20 types of bacteria causing pneumococcal disease.
PCV20 is recommended for adults 65 years or older who have received the PCV13 vaccine at any age. The CDC also recommends pneumococcal vaccination for all children younger than 5 years old. A 4-dose PCV series (PCV15 or PCV20) should be administered, with one dose at each of the following ages: 2 months, 4 months, 6 months, and 12-15 months. If a child is healthy and between the ages of 2 and 5 but didn't complete the four-dose series, they should still get either the PCV15 or PCV20 vaccine and follow the recommended dosing and schedule.
It is important to note that pneumococcal vaccines cannot prevent all cases of pneumonia, but they can lower the chances of catching the infection. Most people only need to get one pneumonia vaccine, and it lasts for a lifetime.
Antivaxxers Claim Aborted Fetuses in Vaccines: Truth or Myth?
You may want to see also
Explore related products
$11.93 $21.99

PCV15 and PCV20 side effects
Pneumonia is a serious disease that infects the air sacs of the lungs, causing them to fill with fluid or pus. It can result in a cough, fever, chills, and trouble breathing. It is caused by pneumococcal bacteria, which the pneumonia vaccine helps prevent.
There are two types of pneumococcal vaccines: Pneumococcal conjugate vaccines (PCVs) and pneumococcal polysaccharide vaccines (PPSV23). PCV15 and PCV20 are types of PCVs. PCV15 protects against 15 types of bacteria that cause pneumococcal disease, and PCV20 protects against 20 types. PCV15 and PCV20 are relatively new vaccines, having been approved for use in adults in 2022 and 2023, respectively. They are also recommended for children under five years old.
PCV15 and PCV20 have similar side effects, which are usually mild and go away within a few days. These include redness, swelling, or pain at the injection site. Most people who receive either vaccine do not experience serious problems. However, serious reactions are possible, and those with a history of severe allergic reactions to any type of PCV or vaccines containing diphtheria toxoid should not receive either PCV15 or PCV20.
Meningitis Vaccine: Know the Name, Protect Yourself
You may want to see also
Explore related products

Who should get vaccinated?
Pneumococcal disease is caused by bacteria that commonly live in the nose and throat and can cause mild infections, such as ear infections, as well as more serious infections, including pneumonia, sinus infections, meningitis, and bloodstream infections. Pneumonia is a serious disease that infects the air sacs of the lungs, causing them to fill with fluid or pus, and can quickly become life-threatening, especially for older adults with other health conditions or a weakened immune system.
The CDC recommends pneumococcal vaccination for many adults based on age, certain risk conditions, and pneumococcal vaccines already received. In the United States, there are two types of pneumococcal vaccines recommended for seniors aged 65 or older: PCV15 and PCV20. PCV15 protects against 15 types of bacteria that cause pneumococcal disease, while PCV20 protects against 20 types. Both types of vaccines are considered safe and effective, but they cannot be administered simultaneously. Adults 65 years or older have the option to receive either PCV20 or PCV21 or to forgo additional pneumococcal vaccines.
In addition to seniors, the CDC recommends routine pneumococcal vaccination for all children younger than five years old, ideally starting when they are younger than two. A four-dose PCV series (PCV15 or PCV20) should be administered, with one dose at each of the following ages: 2 months, 4 months, 6 months, and 12-15 months. Children younger than five who miss their shots or start the series later than recommended should still receive either PCV15 or PCV20, following the recommended dosing and schedule. PCVs are also recommended for children aged 5 or younger and older than 5 through 18 years of age with certain medical conditions.
Furthermore, adults younger than 50 years old with a weakened immune system or certain medical conditions may also be advised to receive pneumococcal vaccines. This includes individuals with heart disease, sickle cell disease, chronic liver disease, diabetes, emphysema, asthma, or chronic obstructive pulmonary disease (COPD). People who smoke cigarettes, receive chemotherapy, have had organ transplants, or have HIV or AIDS are also at higher risk and may need vaccination.
Which Vaccines Have I Taken? Check Your Records
You may want to see also
Frequently asked questions
The two types of pneumonia vaccines for seniors are the pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PPSV23).
Anyone aged 50 or older should get the pneumonia vaccine, especially those with a weakened immune system. Pneumonia can quickly become life-threatening for older adults with other health conditions or a weakened immune system.
Most people only need to get one pneumonia vaccine for a lifetime. However, the recommended number of doses and intervals between doses will depend on the patient's age and vaccination history.
Most people who get the pneumonia vaccine do not experience any serious side effects. The side effects are usually mild and go away within about two days. These may include redness, swelling, or pain at the injection site.
You can get the pneumonia vaccine at a healthcare provider's office or pharmacy. Federally funded health centres can also provide the vaccine if you do not have a regular source of healthcare.











































